Portal de Periódicos da CAPES

Prediction of lung cancer using volatile biomarkers in breath1

2007; IOS Press; Volume: 3; Issue: 2 Linguagem: Inglês

10.3233/cbm-2007-3204

1875-8592

Michael Phillips, Nasser K. Altorki, John H. M. Austin, Robert B. Cameron, Renee N. Cataneo, Joel Greenberg, Robert Kloss, Roger A. Maxfield, Muhammad I. Munawar, Harvey I. Pass, Asif Rashid, William N. Rom, Peter Schmitt,

Insect Pheromone Research and Control

Background: Normal metabolism generates several volatile organic compounds (VOCs) that are excreted in the breath (e.g. alkanes). In patients with lung cancer, induction of high-risk cytochrome p450 genotypes may accelerate catabolism of these VOCs,